SCHEMBL16463142

SCHEMBL16463142

COc1ccc(C[C@H](NC(=O)[C@H](C)NS(=O)(=O)c2ccccc2)C(=O)OCc2ccccc2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP2 P08253 1/20 0.55
MMP9 P14780 1/20 0.55
BMP1 P13497 2/20 0.54
ALDH1A1 P00352 3/20 0.51
HSD17B10 Q99714 3/20 0.51
HPGD P15428 2/20 0.51
TSHR P16473 2/20 0.51
KDM4E B2RXH2 1/20 0.51
USP2 O75604 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
MMP1 P03956 3/20 0.50
HDAC8 Q9BY41 1/20 0.49
REN P00797 1/20 0.49
CTSL P07711 1/20 0.48
CTSS P25774 1/20 0.48
CTSK P43235 1/20 0.48
CA1 P00915 1/20 0.48
CA2 P00918 1/20 0.48
ACHE P22303 1/20 0.48
POLB P06746 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16464420 0.88 MMP1 (0.47) MMP2MMP9BMP1ALDH1A1HSD17B10
SCHEMBL16464425 0.88 MMP1 (0.47) MMP2MMP9BMP1ALDH1A1HSD17B10
SCHEMBL16461731 0.88 MMP2 (0.63) MMP2MMP9ALDH1A1HSD17B10HPGD
SCHEMBL5572756 0.86 CTSL (0.58) MMP2MMP9ALDH1A1HSD17B10CTSL
SCHEMBL19316083 0.83 MMP1 (0.55) ALDH1A1HSD17B10TSHRMMP1HDAC8
SCHEMBL16463156 0.82 CAPN1 (0.54) MMP2MMP9BMP1ALDH1A1HSD17B10
SCHEMBL18603586 0.82 MMP1 (0.56) MMP9ALDH1A1HSD17B10TSHRMMP1
SCHEMBL8107011 0.81 CTSK (0.61) ALDH1A1HSD17B10TSHRMMP1HDAC8
SCHEMBL8100024 0.81 CTSK (0.61) ALDH1A1HSD17B10TSHRMMP1HDAC8
SCHEMBL12052762 0.81 CTSK (0.61) ALDH1A1HSD17B10TSHRMMP1HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150274777-A1 KETOAMIDE IMMUNOPROTEASOME INHIBITORS HOFFMANN-LA ROCHE INC. 2015-10-01 US disclosed
EP-2906581-A1 KETOAMIDE IMMUNOPROTEASOME INHIBITORS F. Hoffmann-La Roche AG (CH) 2015-08-19 EP disclosed
WO-2014056748-A1 KETOAMIDE IMMUNOPROTEASOME INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2014-04-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150274777-A1 KETOAMIDE IMMUNOPROTEASOME INHIBITORS PSMB7, PSMB5, PSMC2 MMP2 1812/4885MMP9 2669/4885BMP1 4797/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.